Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display

Virology
Julia C FreiJonathan R Lai

Abstract

Here we investigated the binding of Dengue virus envelope glycoprotein domain III (DIII) by two broadly neutralizing antibodies (bNAbs), 4E11 and 4E5A. There are four serotypes of Dengue virus (DENV-1 to -4), whose DIII sequences vary by up to 49%. We used combinatorial alanine scanning mutagenesis, a phage display approach, to map functional epitopes (those residues that contribute most significantly to the energetics of antibody-antigen interaction) on these four serotypes. Our results showed that 4E11, which binds strongly to DENV-1, -2, and -3, and moderately to DENV-4, recognized a common conserved core functional epitope involving DIII residues K310, L/I387, L389, and W391. There were also unique recognition features for each serotype, suggesting that 4E11 has flexible recognition requirements. Similar scanning studies for the related bNAb 4E5A, which binds more tightly to DENV-4, identified broader functional epitopes on DENV-1. These results provide useful information for immunogen and therapeutic antibody design.

References

Jul 1, 1977·The Journal of Experimental Medicine·S B Halstead, E J O'Rourke
Jan 20, 1995·Science·T Clackson, J A Wells
Jun 13, 1997·Science·G J WedemayerR C Stevens
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·G A WeissS S Sidhu
May 13, 2003·Nature Structural Biology·Yili LiRoy A Mariuzza
May 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yorgo ModisStephen C Harrison
Jul 10, 2003·Journal of Molecular Biology·Jun YinPeter G Schultz
Aug 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Frederic A FellouseSachdev S Sidhu
Apr 28, 2005·Journal of Molecular Biology·Frederic A FellouseSachdev S Sidhu
Sep 1, 2005·Protein Science : a Publication of the Protein Society·Gábor PálSachdev S Sidhu
Mar 6, 2007·Journal of Immunological Methods·Yariv MazorItai Benhar
Sep 11, 2007·Journal of Molecular Biology·Frederic A FellouseSachdev S Sidhu
Feb 12, 2008·Nature Structural & Molecular Biology·Shee-Mei LokMichael G Rossmann
Jul 4, 2008·Nature Structural & Molecular Biology·Stephen C Harrison
Sep 18, 2008·Virus Research·Alienys IzquierdoMaría G Guzmán
Dec 20, 2008·PLoS Pathogens·Hilde M van der SchaarJolanda M Smit
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
Aug 13, 2010·Journal of Virology·James D BrienMichael S Diamond
Oct 16, 2010·PLoS Pathogens·Elena ZaitsevaLeonid V Chernomordik
Jan 31, 2012·Structure·Joseph J B CockburnFelix A Rey
Feb 23, 2012·Viruses·Wahala M P B Wahala, Aravinda M de Silva
May 9, 2012·PLoS Neglected Tropical Diseases·Pi-Chun LiHan-Chung Wu
Jun 30, 2012·Proceedings of the National Academy of Sciences of the United States of America·Anthony P WestPamela J Bjorkman
Dec 12, 2012·Journal of Molecular Biology·Helena PerssonSachdev S Sidhu
Apr 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kannan TharakaramanRam Sasisekharan

❮ Previous
Next ❯

Citations

May 3, 2019·Molecular Systems Biology·Srivamshi PittalaChris Bailey-Kellogg
Aug 22, 2018·Proceedings of the National Academy of Sciences of the United States of America·Michal JuraskaPeter B Gilbert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.